Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Family Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, MRCP (UK), PCRC, Kidney dialysis certified
Endocrinologist
M.B.B.S., F.C.P.S., Fellowship Endocrinology and Diabetes
General Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S. (Medicine)
Endocrinologist
M.B.B.S., MSc., P.E.C
Internal Medicine Specialist
MBBS, MRCP II, FCPS (Medicine), Fellowship in Endocrinology
Internal Medicine Specialist
MBBS, MRCP II, FCPS (Medicine), Fellowship in Endocrinology
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures